about
Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes.Uterine leiomyosarcoma: a review of recent advances in molecular biology, clinical management and outcome.Trabectedin and Eribulin: Where Do They Fit in the Management of Soft Tissue Sarcoma?Prognostic value of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with cutaneous angiosarcoma: A retrospective study of 18 cases.Gemcitabine and Docetaxel Combination for Advanced Soft Tissue Sarcoma: A Nationwide Retrospective Study.Malignant glomus tumors of the head and neck in children and adults: Evaluation and management.Activity of anthracycline- and ifosfamide-based chemotherapy in a series of patients affected by advanced myxofibrosarcoma.High-Dose Ifosfamide Chemotherapy in a Series of Patients Affected by Myxoid Liposarcoma.Managing sarcoma: where have we come from and where are we going?Antitumor effects of pristimerin on human osteosarcoma cells in vitro and in vivo.Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma.Advances in the treatment of soft tissue sarcoma: focus on eribulin.Surgical considerations when reporting MRI studies of soft tissue sarcoma of the limbs.PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas.Pulmonary artery intramural leiomyosarcoma mimicking pulmonary aneurysm.Soft-tissue Sarcomas.
P2860
Q38699774-D2AB8D40-A488-481C-A5A3-C2FED2ECF17CQ38765107-6991F344-7399-4E6A-89C6-164EA0FFD541Q38769613-6F8D8BA5-11BF-416C-A233-0936CC9C8798Q38859528-765330C4-2FC4-4FCA-84BE-F31FF9D04ED6Q38865404-DF76EE2A-932D-47D7-B0FB-298A1D8D3C20Q39179092-109305E0-1864-4085-8654-4A998A1329D4Q41501364-F9F7C341-C6FC-4239-AC5E-6122BC710525Q41694851-433DF63B-2324-4FC4-8F85-94D779718AC1Q41988197-4AC4C98B-0520-43F4-9260-ED1384A82643Q47096522-8AC0F2B7-197A-4582-A0F8-CA96BD8D5AC5Q47148669-44EB94BF-E286-41D8-A0A9-72806E5A97A2Q49261685-4575C68C-0E3F-42BA-A49E-6A341DCD1A18Q50201314-136DA6D7-06E1-4F11-827A-5FCD3EEA5405Q52682430-A76E42AA-F99F-4713-8510-0664DE79B9B9Q52947730-C5D38EC3-9AF4-4F04-9FF5-14AA3921E67CQ55030777-642634F9-5505-43EB-9F39-A9183EEA2BB9
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Chemotherapy for soft tissue sarcoma.
@en
type
label
Chemotherapy for soft tissue sarcoma.
@en
prefLabel
Chemotherapy for soft tissue sarcoma.
@en
P2860
P356
P1433
P1476
Chemotherapy for soft tissue sarcoma.
@en
P2093
Ravin Ratan
Shreyaskumar R Patel
P2860
P304
P356
10.1002/CNCR.30191
P407
P577
2016-07-19T00:00:00Z